Maltodextrin May Be a Promising Treatment Modality After Near-total Pancreatectomy in Infants Younger Than Six Months with Persistent Hyperinsulinism: A Case Report.

Creative Commons License

Denkboy Ongen Y., Eren E., Saglam H.

Journal of clinical research in pediatric endocrinology, vol.15, pp.103-107, 2023 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15
  • Publication Date: 2023
  • Doi Number: 10.4274/jcrpe.galenos.2021.2021.0121
  • Journal Name: Journal of clinical research in pediatric endocrinology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.103-107
  • Keywords: Congenital hyperinsulinism, ABCC8 gene, maltodextrin, near -total pancreatectomy, continue glucose monitoring systems, DIAGNOSIS, MANAGEMENT
  • Bursa Uludag University Affiliated: Yes


Persistent hypoglycemia in infants with congenital hyperinsulinism (CHI) can be challenging in approximately half of these cases, even after undergoing a near-total pancreatectomy. While maltodextrin has been recommended in the nutritional management of CHI cases younger than six months, information regarding its efficacy in managing hypoglycemia are not yet clear. Here, we present a male infant with CHI who experienced persistent hypoglycemia even after undergoing a near-total pancreatectomy and despite multiple medical treatments. The infant's hypoglycemic episodes were successfully controlled by adding maltodextrin to his diet.